HOME >> BIOLOGY >> NEWS
Yale researcher testifies in support of embryonic stem cell research

Yale researcher Diane Krause testified today before the Senate Appropriations Subcommittee urging Congress to continue federal funding for embryonic stem cell research.

Krause, associate professor of laboratory medicine and pathology at Yale School of Medicine, has done extensive research on adult stem cells. She recently discovered adult stem cells in bone marrow that can create new liver, lung, gastrointestinal and skin cells, and possibly any other organ in the body.

"While I am very excited about this research, it is important that the subcommittee understand that adult stem cell research is not a substitute for embryonic stem cell research," Krause said in her testimony. "The progress made in studying adult stem cells relies on what has been learned from embryonic stem cell studies."

Krause stressed the importance of embryonic stem cell research and the need for the administration to allow federally funded embryonic stem cell studies to proceed. "It is my testimony that these two areas of research together will lead to effective and safe treatments for life-threatening diseases," she said.

Krause told the subcommittee that it is not yet known whether adult stem cells have the same ability as embryonic cells to become all cell types. She also said that in order for scientific discovery to continue rapidly, both adult and embryonic stem cells would need to be studied and compared. She said far more information can be obtained from embryonic stem cells, which are the "experts" in plasticity, than from adult derived cells.

"Work on embryonic stem cells is invaluable and work on adult derived stem cells is just beginning," Krause said. "To close off one avenue because of premature assumptions about the other is to play the odds with people's lives. I am speaking not only for myself, but also for other members of the scientific and medical community and specifically on behalf of the American Society of Hematology, which has ov
'"/>

Contact: Karen N. Peart
karen.peart@yale.edu
203-432-1326
Yale University
18-Jul-2001


Page: 1 2

Related biology news :

1. Belgian researchers explore revolutionary approach to angiogenesis
2. Award winning researchers reveal potential new role for Glivec
3. University of Alberta researcher looks for clues to mysterious disease
4. $7.5 Million grant to Yale researchers for role of viruses in cancer
5. New anti-inflammatory strategy for cancer therapy identified by UCSD researchers
6. Joslin researchers clarify mechanisms for beta-cell formation
7. Pioneering AIDS researcher to speak at UH
8. Defensive action by influenza viruses demonstrated by Hebrew university researcher
9. Virginia Tech researchers to release findings on Smith River Project
10. Molecular motor myosin VI moves hand over hand, researchers say
11. Tiny molecules have big potential as cancer drugs, Stanford researcher believes

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:6/23/2020)... ... ... The field of quantitation of large molecules or proteins has been around for ... use of mass spectrometry in this field has gained a lot of momentum in ... which approach to use (LBA or MS)?” In many cases, either technology can ...
(Date:6/23/2020)... ... 2020 , ... In its June 22 online post, business and technology news ... M.D., Ph.D., founder and director of stem cell biotechnology company Asymmetrex . Superb ... that starting July 5 it would begin offering free tissue stem cell counting ...
(Date:6/19/2020)... SAN DIEGO (PRWEB) , ... ... ... host a three-part webinar series, “Automate Your Lab with Software for Data ... engineers. Attendees will learn how to integrate and automate cutting-edge scientific instruments ...
Breaking Biology News(10 mins):
(Date:8/12/2020)... ... August 11, 2020 , ... ... chain validation engineering firm, is making available for free its new white ... incorporate concurrent transport simulation testing into today’s biologics licensing application (BLA). In ...
(Date:8/7/2020)... Texas (PRWEB) , ... August 06, 2020 , ... ... and DNA vaccine industries, announces it has closed on the purchase of greenfield ... Park in Conroe, TX and includes over 21 acres in the initial acquisition, ...
(Date:8/3/2020)... ... , ... Introducing Ardent Animal Health – MediVet Biologics rebrands company and positions ... as MediVet Biologics since its formation in 2016, the company is relaunching itself under ... build on its base of innovative therapies for osteoarthritis and cancer. , ...
(Date:7/31/2020)... ... July 29, 2020 , ... G-CON Manufacturing, the leader ... tagline, “BUILDING FOR LIFE.” The adoption of this taglines comes at a time ... track capacity to provide patients with urgently needed vaccines and other lifesaving pharmaceutical ...
Breaking Biology Technology:
Cached News: